ATE173087T1 - Verfahren zur messung metaplastischer veränderungen von schleimabsondernden epithelzellen - Google Patents
Verfahren zur messung metaplastischer veränderungen von schleimabsondernden epithelzellenInfo
- Publication number
- ATE173087T1 ATE173087T1 AT94925314T AT94925314T ATE173087T1 AT E173087 T1 ATE173087 T1 AT E173087T1 AT 94925314 T AT94925314 T AT 94925314T AT 94925314 T AT94925314 T AT 94925314T AT E173087 T1 ATE173087 T1 AT E173087T1
- Authority
- AT
- Austria
- Prior art keywords
- assay
- metaplastic
- neutral
- animal
- removal
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 210000002919 epithelial cell Anatomy 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 3
- 230000002378 acidificating effect Effects 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000007935 neutral effect Effects 0.000 abstract 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 206010054949 Metaplasia Diseases 0.000 abstract 1
- 102000001621 Mucoproteins Human genes 0.000 abstract 1
- 108010093825 Mucoproteins Proteins 0.000 abstract 1
- 238000010171 animal model Methods 0.000 abstract 1
- 239000008366 buffered solution Substances 0.000 abstract 1
- 239000003638 chemical reducing agent Substances 0.000 abstract 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000005194 fractionation Methods 0.000 abstract 1
- 238000000265 homogenisation Methods 0.000 abstract 1
- 206010020718 hyperplasia Diseases 0.000 abstract 1
- 230000002390 hyperplastic effect Effects 0.000 abstract 1
- 230000001969 hypertrophic effect Effects 0.000 abstract 1
- 239000000411 inducer Substances 0.000 abstract 1
- 210000004072 lung Anatomy 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000015689 metaplastic ossification Effects 0.000 abstract 1
- 210000003097 mucus Anatomy 0.000 abstract 1
- 230000002182 neurohumoral effect Effects 0.000 abstract 1
- 239000013618 particulate matter Substances 0.000 abstract 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 abstract 1
- 238000010186 staining Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
- G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25125—Digestion or removing interfering materials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/25375—Liberation or purification of sample or separation of material from a sample [e.g., filtering, centrifuging, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12071993A | 1993-09-13 | 1993-09-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE173087T1 true ATE173087T1 (de) | 1998-11-15 |
Family
ID=22392139
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94925314T ATE173087T1 (de) | 1993-09-13 | 1994-08-30 | Verfahren zur messung metaplastischer veränderungen von schleimabsondernden epithelzellen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US5932481A (de) |
| EP (1) | EP0719412B1 (de) |
| JP (1) | JP3436311B2 (de) |
| AT (1) | ATE173087T1 (de) |
| CA (1) | CA2171477C (de) |
| DE (1) | DE69414405T2 (de) |
| DK (1) | DK0719412T3 (de) |
| ES (1) | ES2123818T3 (de) |
| WO (1) | WO1995008114A1 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6897198A (en) * | 1997-04-11 | 1998-11-11 | Beth Israel Deaconess Medical Center | Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions |
| CA2337422C (en) * | 1998-08-18 | 2010-11-02 | The Regents Of The University Of California | Preventing airway mucus production by administration of egf-r antagonists |
| US7354894B2 (en) | 1998-08-18 | 2008-04-08 | The Regents Of The University Of California | Preventing airway mucus production by administration of EGF-R antagonists |
| KR100753899B1 (ko) | 2005-12-27 | 2007-08-31 | 재단법인서울대학교산학협력재단 | 알시안 블루를 이용한 시각화 방법 |
| US9833207B2 (en) | 2012-08-08 | 2017-12-05 | William Harrison Zurn | Analysis and clearing module, system and method |
| US9962533B2 (en) | 2013-02-14 | 2018-05-08 | William Harrison Zurn | Module for treatment of medical conditions; system for making module and methods of making module |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4078090A (en) * | 1974-11-13 | 1978-03-07 | S.A. Joullie International | (Carboxymethylthio)acetic acid and salts thereof used as mucolytic agents |
| JP2517293B2 (ja) * | 1987-06-25 | 1996-07-24 | メクト株式会社 | 細胞、組織修復剤 |
-
1994
- 1994-08-30 AT AT94925314T patent/ATE173087T1/de not_active IP Right Cessation
- 1994-08-30 DK DK94925314T patent/DK0719412T3/da active
- 1994-08-30 JP JP50887395A patent/JP3436311B2/ja not_active Expired - Fee Related
- 1994-08-30 ES ES94925314T patent/ES2123818T3/es not_active Expired - Lifetime
- 1994-08-30 CA CA002171477A patent/CA2171477C/en not_active Expired - Fee Related
- 1994-08-30 EP EP94925314A patent/EP0719412B1/de not_active Expired - Lifetime
- 1994-08-30 DE DE69414405T patent/DE69414405T2/de not_active Expired - Fee Related
- 1994-08-30 WO PCT/CA1994/000473 patent/WO1995008114A1/en not_active Ceased
-
1998
- 1998-03-23 US US09/046,085 patent/US5932481A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0719412A1 (de) | 1996-07-03 |
| EP0719412B1 (de) | 1998-11-04 |
| US5932481A (en) | 1999-08-03 |
| CA2171477C (en) | 2004-10-19 |
| ES2123818T3 (es) | 1999-01-16 |
| DK0719412T3 (da) | 1999-07-19 |
| CA2171477A1 (en) | 1995-03-23 |
| DE69414405D1 (de) | 1998-12-10 |
| DE69414405T2 (de) | 1999-06-10 |
| WO1995008114A1 (en) | 1995-03-23 |
| JP3436311B2 (ja) | 2003-08-11 |
| JPH09502524A (ja) | 1997-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Burcham et al. | Introduction of carbonyl groups into proteins by the lipid peroxidation product, malondialdehyde | |
| ATE320505T1 (de) | Verfahren zur bestimmung von nukleinsäuresequenzen in urin | |
| SE0000538L (sv) | Metoder och kit för analytdetektion mha proximitets-probning | |
| BR9708780A (pt) | "aparelho para detecção magnética da mais alta sensibilidade de analitos ". | |
| ATE253645T1 (de) | Verfahren zur bestimmung von säugetier nukleinsäuren aus stuhlproben und dafür benötigte reagenzien | |
| DE69011198D1 (de) | Verfahren zur Differenzierung von Leukozyten mit Hilfe eines Durchflusszellmessgerätes. | |
| SE8804074D0 (sv) | Sensorenhet och dess anvaendning i biosensorsystem | |
| DE69939121D1 (de) | Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden | |
| DE69228882D1 (de) | Verfahren und vorrichtung zur quantifizierung von relevanten blutparametern | |
| JP2022176209A (ja) | 抗レプチン中和抗体を検出する方法 | |
| ATE173087T1 (de) | Verfahren zur messung metaplastischer veränderungen von schleimabsondernden epithelzellen | |
| ATE350659T1 (de) | Verfahren zur identifizierung von proben eines säugetiers als auch ein kit zur durchführung des verfahrens | |
| ATE220112T1 (de) | Verfahren zum nachweis von störungen des protein c/protein s-systems | |
| DK0883693T3 (da) | Fremgangsmåde til kvantitativ bestemmelse af en nukleinsyre i opløsning ved måling af den elektriske konduktivitet og appar | |
| DE69836713D1 (de) | Verfahren zur Verbesserung der Genauigkeit von der semi-quantitativen Bestimmung eines Analyts in flüssigen Proben | |
| ATE392484T1 (de) | Verbessertes verfahren zur membranpotentialmessung | |
| Valverde et al. | The application of single cell gel electrophoresis or comet assay to human monitoring studies | |
| Viglio et al. | Progress in the methodological strategies for the detection in real samples of desmosine and isodesmosine, two biological markers of elastin degradation | |
| Otey et al. | A procedure for the immunoblotting of proteins separated on isoelectric focusing gels | |
| Lundebye et al. | Improved quantification of stress proteins by western blotting | |
| Kessler et al. | Procollagen C-proteinase enhancer 1 (PCPE-1) in liver fibrosis | |
| EP1156121B1 (de) | Chelatbildner enthaltendes Harn-Trypsininhibitor-Assay | |
| DE69929817D1 (de) | Verfahren zur aktivitätsbestimmung einer substanz mittels eines funktionellen in vitro tests | |
| DE59807515D1 (de) | Vorrichtung zur Erfassung von Parametern eines langgestreckten Prüfguts | |
| Berlingin et al. | Measurement of S phase duration in human epidermis using cyclin immunostaining and 3H-thymidine pulse labelling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REN | Ceased due to non-payment of the annual fee |